The SMARTER Cardiomyopathy Study

Launched by IMPERIAL COLLEGE LONDON · Feb 20, 2023

Keywords

ClinConnect Summary

The SMARTER Cardiomyopathy Study is a research trial aimed at understanding heart muscle diseases, specifically cardiomyopathies like hypertrophic cardiomyopathy and dilated cardiomyopathy. The study seeks to learn more about both genetic factors and other influences that affect how these conditions develop and progress. By collecting DNA, blood samples, and detailed health information from participants over time, the researchers hope to find new ways to diagnose and treat cardiomyopathies. This could ultimately help improve the health and quality of life for those affected by these diseases.

Adults with a confirmed diagnosis of cardiomyopathy, children with parental consent, or individuals with a family history of cardiomyopathy may be eligible to participate. Participants can expect to provide samples and health information at the start of the study and during regular healthcare visits. The goal is to gather a large group of individuals with similar heart conditions to better understand the disease and identify who might respond best to different treatments. This study is currently recruiting participants of all genders and ages, aiming to make significant advancements in cardiomyopathy care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults with the capacity to consent Children with parental/guardian consent Male and Female
• Meeting the following criteria:
• • 1. Patients with a confirmed diagnosis of cardiomyopathy or related condition
• • 2. Patients with a family member with cardiomyopathy, or a related condition
• • 3. Patients with a genetic variant that may predispose to cardiomyopathy, or a related condition
• Exclusion Criteria:
• • Patients without the capacity to provide informed consent